分析了2-乙烯4-甲基酸盐和牛血清蛋白之间的相互作用,同时存在和封装β-环氧二烯
Xinming Li1, Jiali Gu1, Hongrui Liu1
1College of Chemistry and Materials Engineering, Bohai University, Jinzhou, PR China.
概括
-环极素 (β-CD) 封装减弱了防晒剂2-乙4-甲基酸盐 (EHMC) 和牛血清白蛋白 (BSA) 之间的相互作用. 这一发现表明β-CD对EHMC的保护作用.
科学领域:
- 环境化学环境化学
- 生物化学 生物化学
- 材料科学 材料科学 材料科学
背景情况:
- 2-乙4-甲基酸盐 (EHMC) 是防晒中广泛使用的紫外线过器.
- EHMC是一种新兴的环境污染物,已知与牛血清白蛋白 (BSA) 等生物分子相互作用.
- 了解这些相互作用对于评估环境和生物影响至关重要.
研究的目的:
- 在共存和β-环极 (β-CD) 封装的条件下,研究EHMC和BSA之间的相互作用.
- 确定β-CD对BSA中EHMC诱导的结合亲和力和构造变化的影响.
- 评估β-CD封装对EHMC紫外线屏蔽性能的影响.
主要方法:
- 使用光谱技术 (例如光,UV-Vis) 来研究EHMC-BSA相互作用.
- 确定了结合常数和热力学参数.
- 在存在或缺少EHMC和β-CD的情况下进行了BSA的合规分析.
主要成果:
- β-CD显著削弱了EHMC和BSA之间的相互作用,无论是在共存还是封装场景中.
- 在β-CD中封装EHMC导致对BSA的弱结合 (K = (7.63 ± 0.01) ×104 M−1).
- 在BSA中受到EHMC诱导的结构变化被β-CD抑制,从而保留了BSA的原生结构.
结论:
- 包装β-cyclopodextrin有效地减轻了EHMC和BSA之间的有害相互作用.
- β-CD作为一种保护剂,减少了EHMC对蛋白质结构和功能的影响.
- EHMC的紫外线过效率在很大程度上不受β-CD封装的影响.
相关概念视频
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
171
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
171
Factors Affecting Protein-Drug Binding: Drug Interactions
90
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
90
Hepatic Drug Excretion: Enterohepatic Cycling
938
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
938


